Home

Find out the latest news from international oncology congresses and stay at the forefront of clinical innovation and advances in lung cancer research. Each SPECIAL ISSUE – CONGRESS REPORT features informative summaries of key topics from lung cancer to come out of a major international oncology congress.

The memo inOncology Medical education series: keeping oncologists at the forefront of lung cancer research. memo – inOncology Special Issue Preceptorship reports summarise the latest in lung cancer research and treatments to come out of our sponsored Preceptorship meeting series. The Fundamentals of Designing Clinical Trials series arms oncologists with the information they need to plan and conduct an oncology trial.

 

Prof. Garrido gives an overview of the management of patients with stage III NSCLC, novel treatments in stage III disease and recent insights concerning immune modulatory vaccination in patients with NSCLC.

Preceptorship Singapore

Basics of leadership in clinical research with a focus on lung cancer

Young Oncologist Preceptorship, 8th–10th December, 2017, Singapore

memo – inOncology SPECIAL ISSUE
ELCC Congress report 2019
The latest findings in lung cancer to come out of the ELCC Congress held from 10th to 13rd April in Geneva!

News

Springer is delighted to announce a new memo inOncology SPECIAL ISSUE congress report from this years ELCC!

Congress Report ELCC 2018
memo – inOncology SPECIAL ISSUE
Congress Report ELCC 2019 
This report summarizes a selection of abstracts presented at ELCC 2019 in the areas of targeted therapy and immunotherapy for both non-small-cell and small-cell tumors of the lung.

 

 


Springer memo Preceptorship Cologne CoverPreceptorship Shanghai – Modern Management of Advanced Lung Cancer:
Immunotherapy & Targeted Agents
Springer and the Shanghai Pulmonary Hospital held the Lung Cancer International Preceptorship on the 28th-29th June 2018, in Shanghai, China. The overall topic was the modern management of advanced lung cancer: Immunotherapy & Targeted Agents

Access the report here


Expert interviews at ELCC 2019

Prof. Garrido gives an overview of the management of patients with stage III NSCLC, novel treatments in stage III disease and recent insights concerning immune modulatory vaccination in patients with NSCLC.

Dr. Newsom-Davis on the treatment algorithm for ALK-positive NSCLC and future developments for patients with ALK/ROS1-positive tumors.

Prof. Peled talks about the importance of early detection of lung cancer – especially in poorer countries –, promising biomarkers for the early detection and new insights into the interactions between lung cancer cells and the tumor microenvironment.